Orphan Drugs Treatment for Rare Diseases

Drugs that are evolved specifically to treat rare diseases – called “orphan drugs” – often remain economically of Rare Disease Day, it’s worth reanalyse a series of Healthcare Triage videos we updated last year that majorly focuses on orphan drugs, what’s wrong with the undergoing system, and how we might get ridge out of it. Can we people come out of this undergoing worst system situation? An orphan drug is usually defined as that one used to treat orphan diseases for example heam arginate and many more. 

  • Acute intermittent porphyria
  • Variegate porphyria
  • Hereditary coproporphyria
  • Haem arginate

Related Conference of Orphan Drugs Treatment for Rare Diseases

February 04-05, 2026

18th International Conference on Gynecology

Rome, Italy
February 25-26, 2026

15th International Conference on Herbal Medicine and Acupuncture

Aix-en-Provence, France
March 09-10, 2026

13th World Machine Learning and Deep learning Conference

Singapore City, Singapore
March 24-25, 2026

9th Global Congress on Spine and Spinal Disorders

Paris, France
March 26-27, 2026

12th World Congress on Anesthesia and Critical Care

Amsterdam, Netherlands
April 20-21, 2026

47th International Summit on Human Anatomy & Physiology

Barcelona, Spain
April 27-28, 2026

40th International Conference on Psychiatry and Mental Health

Amsterdam, Netherlands
April 27-28, 2026

37th World Congress on Neurorehabilitation

Dubai, UAE
May 25-26, 2026

18th International Conference on Clinical Chemistry

Zurich, Switzerland
September 14-15, 2026

6th World Medicine Congress

Rome, Italy
October 19-20, 2026

12th World Congress on Medicinal Plants and Marine Drugs

Aix-en-Provence, France

Orphan Drugs Treatment for Rare Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in